Inventor · disambiguated record
Julio C. Medina
Also filed as: MEDINA JULIO · MEDINA JULIO C · MEDINA JULIO CESAR
74 granted patents·30 pending applications·1,516 citations·filing 1997–2023
99Inventor score
Files withAMGEN INC49TULARIK INC16ORIC PHARMACEUTICALS INC10REILEY PHARMACEUTICALS INC5AMGEN SF LLC4
Top patents by PatentIndex Score
104 records- 0198US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0298US6794379B2CXCR3 antagonistsTULARIK INC·Filed 2002·Granted Sep 21, 2004·101 cites·23 claims
- 0398US6583161B1Benzenesulfonamides and benzamides as therapeutic agentsTULARIK INC·Filed 2000·Granted Jun 24, 2003·124 cites·50 claims
- 0498US6191170B1Benzenesulfonamides and benzamides as therapeutic agentsTULARIK INC·Filed 1999·Granted Feb 20, 2001·114 cites·42 claims
- 0597US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0697US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0797US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0897US9656998B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·14 cites·16 claims
- 0996US6605615B2Hydrazones and analogs as cholesterol lowering agentsTULARIK INC·Filed 2001·Granted Aug 12, 2003·74 cites·38 claims
- 1095US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 1195US9751864B2Methods for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Sep 5, 2017·14 cites·28 claims
- 1295US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 1395US7541383B2Asthma and allergic inflammation modulatorsAMGEN INC·Filed 2007·Granted Jun 2, 2009·86 cites·24 claims
- 1495US7144903B2CCR4 antagonistsAMGEN INC·Filed 2002·Granted Dec 5, 2006·90 cites·44 claims
- 1595US6316503B1LXR modulatorsTULARIK INC·Filed 2000·Granted Nov 13, 2001·100 cites·47 claims
- 1694US11926622B2Fluoroalkyl-oxadiazoles and uses thereofTENAYA THERAPEUTICS INC·Filed 2022·Granted Mar 12, 2024·3 cites·20 claims
- 1794US11578066B1Fluoroalkyl-oxadiazoles and uses thereofTENAYA THERAPEUTICS INC·Filed 2022·Granted Feb 14, 2023·3 cites·28 claims
- 1894US7582803B2Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2006·Granted Sep 1, 2009·17 cites·19 claims
- 1994US7262204B2Modulation of CCR4 functionCHEMOCENTRYX INC·Filed 2003·Granted Aug 28, 2007·87 cites·18 claims
- 2092US7375102B2Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their useAMGEN SF LLC·Filed 2005·Granted May 20, 2008·27 cites·24 claims
- 2192US7053215B2Substituted Quinazolin-4(3H)-one compounds, compositions, and methods for their useAMGEN SF LLC·Filed 2002·Granted May 30, 2006·47 cites·18 claims
- 2291US7939538B2Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseasesAMGEN INC·Filed 2005·Granted May 10, 2011·20 cites·23 claims
- 2391US7067662B2CXCR3 antagonistsAMGEN SF LLC·Filed 2004·Granted Jun 27, 2006·31 cites·20 claims
- 2490US10472387B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Nov 12, 2019·2 cites·6 claims
- 2590US6964967B2Substituted pyrido[2,3-d]pyrimidines and methods for their useAMGEN INC·Filed 2001·Granted Nov 15, 2005·35 cites·28 claims
- 2689US7816367B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Oct 19, 2010·15 cites·25 claims
- 2789US7799795B2Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disordersAMGEN INC·Filed 2006·Granted Sep 21, 2010·21 cites·17 claims
- 2888US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 2988US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 3088US7321001B2Asthma and allergic inflammation modulatorsAMGEN INC·Filed 2003·Granted Jan 22, 2008·39 cites·25 claims
- 3188US6884782B2STAT modulatorsAMGEN INC·Filed 2001·Granted Apr 26, 2005·23 cites·102 claims
- 3288US6380249B1HIV integrase inhibitorsMERCK & CO INC·Filed 1999·Granted Apr 30, 2002·51 cites·21 claims
- 3387US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 3486US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 3586US8030354B2Substituted biphenyl GPR40 modulatorsAMGEN INC·Filed 2008·Granted Oct 4, 2011·11 cites·96 claims
- 3685US11634396B2Opioid receptor modulatorsEPIODYNE INC·Filed 2022·Granted Apr 25, 2023·1 cites·16 claims
- 3785US7649110B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Jan 19, 2010·8 cites·37 claims
- 3884US6316484B1Pentafluorobenzenesulfonamides and analogsTULARIK INC·Filed 2000·Granted Nov 13, 2001·13 cites·14 claims
- 3983US8450522B2Conformationally constrained carboxylic acid derivatives useful for treating metabolic disordersBROWN SEAN P·Filed 2009·Granted May 28, 2013·9 cites·17 claims
- 4083US7687526B2Benzo-fused compounds for use in treating metabolic disordersAMGEN INC·Filed 2007·Granted Mar 30, 2010·5 cites·18 claims
- 4182US11352316B2Opioid receptor modulators and products and methods related theretoEPIODYNE INC·Filed 2020·Granted Jun 7, 2022·1 cites·20 claims
- 4282US6388131B2Benzene compounds as antiproliferative and cholesterol lowering agentsTULARIK INC·Filed 2001·Granted May 14, 2002·10 cites·27 claims
- 4382US6306891B1HIV integrase inhibitorsMERCK & CO INC·Filed 1999·Granted Oct 23, 2001·69 cites·31 claims
- 4481US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 4580US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 4680US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 4779US12312345B2Fluoroalkyl-oxadiazoles and uses thereofTENAYA THERAPEUTICS INC·Filed 2023·Granted May 27, 2025·0 cites·32 claims
- 4879US11124537B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 21, 2021·1 cites·23 claims
- 4979US6906069B1LXR modulatorsAMGEN INC·Filed 2000·Granted Jun 14, 2005·18 cites·24 claims
- 5078US7465804B2Compounds, pharmaceutical compositions and methods for their use in treating metabolic disordersAMGEN INC·Filed 2006·Granted Dec 16, 2008·3 cites·48 claims
Showing the top 50 of 104 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Julio C. Medina files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →